These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8590319)

  • 1. Establishment of new interferon-gamma-resistant mutant cells with dominant phenotypes.
    Ohta T; Ando O; Kurimoto M
    J Interferon Cytokine Res; 1995 Feb; 15(2):153-60. PubMed ID: 8590319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA; Lingwood CA
    J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
    Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
    J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.
    Burke F; Smith PD; Crompton MR; Upton C; Balkwill FR
    Br J Cancer; 1999 Jun; 80(8):1236-44. PubMed ID: 10376977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
    Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
    J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
    Yim JH; Ro SH; Lowney JK; Wu SJ; Connett J; Doherty GM
    J Interferon Cytokine Res; 2003 Sep; 23(9):501-11. PubMed ID: 14565859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the IRF-1 transcription factor in antiviral responses to interferons.
    Kimura T; Nakayama K; Penninger J; Kitagawa M; Harada H; Matsuyama T; Tanaka N; Kamijo R; Vilcek J; Mak TW
    Science; 1994 Jun; 264(5167):1921-4. PubMed ID: 8009222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse adenovirus type 1 replication in vitro is resistant to interferon.
    Kajon AE; Spindler KR
    Virology; 2000 Aug; 274(1):213-9. PubMed ID: 10936102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementation of the interferon alpha response in resistant cells by expression of the cloned subunit of the interferon alpha receptor. A central role of this subunit in interferon alpha signaling.
    Colamonici OR; Porterfield B; Domanski P; Constantinescu S; Pfeffer LM
    J Biol Chem; 1994 Apr; 269(13):9598-602. PubMed ID: 8144546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells.
    Ronni T; Sareneva T; Pirhonen J; Julkunen I
    J Immunol; 1995 Mar; 154(6):2764-74. PubMed ID: 7876547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cells.
    Takenaga K
    Br J Cancer; 1999 Apr; 80(1-2):127-32. PubMed ID: 10389988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel IRF-1-deficient mutant cell line.
    Lim SP; Hui KM
    Immunogenetics; 1994; 39(3):168-77. PubMed ID: 7506233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes.
    Kano A; Haruyama T; Akaike T; Watanabe Y
    Biochem Biophys Res Commun; 1999 Apr; 257(3):672-7. PubMed ID: 10208842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
    Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
    Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
    Basu A; Meyer K; Ray RB; Ray R
    Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production.
    Flodström M; Eizirik DL
    Endocrinology; 1997 Jul; 138(7):2747-53. PubMed ID: 9202213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication.
    Dummer R; Döbbeling U; Geertsen R; Willers J; Burg G; Pavlovic J
    Blood; 2001 Jan; 97(2):523-7. PubMed ID: 11154232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense manganese superoxide dismutase mRNA inhibits the antiviral action of interferon-gamma and interferon-alpha.
    Raineri I; Huang TT; Epstein CJ; Epstein LB
    J Interferon Cytokine Res; 1996 Jan; 16(1):61-8. PubMed ID: 8640453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
    Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
    Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.